Physician profile
Christopher Calcagni
NPI 1285863985
$5,525.61
in general payments reported to CMS, 2019-2025
23 companies · $151 in 2025
The $151 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $805 · 2020: $945 · 2021: $1,598 · 2022: $1,514 · 2023: $355 · 2024: $157 · 2025: $151.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $663.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $662.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $3,364.28 | 2020-2025 | Distal Extremities Implants Foot & Ankle Bunion |
| Arthrosurface Incorporated | $607.81 | 2019 | |
| Organogenesis INC. | $551.82 | 2019-2025 | Via Matrix, Simplimax, Puraply |
| Smith+Nephew, INC. | $180.61 | 2020-2024 | Collagenase Santyl, Grafix, Grafix Pl |
| Kerecis Limited | $107.43 | 2022-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Grt US Holding, INC. | $91.47 | 2022 | |
| Treace Medical Concepts, INC. | $82.74 | 2022-2025 | |
| Nevro Corp. | $69.84 | 2023-2024 | Senza |
| Medtronic Vascular, INC. | $64.29 | 2019 | |
| Wright Medical Technology, INC. | $55.35 | 2020 | |
| Paratek Pharmaceuticals, INC. | $53.78 | 2023-2025 | Nuzyra |
| Flower Orthopedics Coporation | $46.22 | 2021 | |
| Horizon Therapeutics Plc | $40.33 | 2021-2023 | Krystexxa |
| Abbvie INC. | $32.83 | 2023-2024 | Dalvance |
| Averitas Pharma INC. | $31.18 | 2023 | Qutenza |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $24.56 | 2023 | Intellis Adaptivestim |
| Depuy Synthes Sales INC. | $23.81 | 2019 | |
| Bioventus LLC | $22.35 | 2021 | |
| Djo, LLC | $17.05 | 2024 | Cmf |
| Cardiovascular Systems INC. | $15.84 | 2019 | |
| Kci USA, INC. | $15.31 | 2023 | Activ.A.C., Promogran Prisma, 3m Coban |
| Reprise Biomedical, INC. | $13.36 | 2024 | Miro3d |
| Omeza LLC | $13.35 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Calcagni listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.